Lactation mastitis is a debilitating inflammatory breast disease in postpartum women. Disease severity is associated with markers of inflammation rather than bacterial load, suggesting that immune-signaling pathways activated in the host are important in the disease pathology. The role of the innate pattern recognition receptor toll-like receptor 4 (TLR4) in progression and resolution of mastitislike disease was investigated in a mouse model. Lipopolysaccharide in Matrigel (10 lg/ 10 ll) was administered into the teat canal of lactating Tlr4 null mutant and wild-type mice to induce a localized area of inflammation. Mastitis induction resulted in a marked influx of RB6-positive neutrophils and F4/80-positive macrophages, which was higher in Tlr4 À/À mice compared to wild-type mice. Tlr4 null mutation resulted in an altered immune-signaling fingerprint following induction of mastitis, with attenuated serum cytokines, including CXCL1, CCL2, interleukin 1 beta, and tumor necrosis factor alpha compared to wild-type mice. In both genotypes, the localized area of inflammation had resolved after 7 days, and milk protein was evident. However, the mammary glands of wild-type mice exhibited reduced capacity for milk production, with decreased percent area populated with glandular epithelium and decreased abundance of nuclear phosphorylated signal transducer and activator of transcription 5 compared to Tlr4 null mice. This study demonstrates that inflammatory pathways activated in the host are critically important in mastitis disease progression and suggests that lactation insufficiency associated with mastitis may be a consequence of TLR4-mediated inflammation, rather than the bacterial infection itself.
INTRODUCTION
Lactation mastitis is a debilitating inflammatory breast disease. Prospective cohort studies have reported the cumulative incidence of lactation mastitis to be between 10% and 27% of breastfeeding women [1] [2] [3] [4] [5] . In HIV-infected women, mastitis increases the viral load in breast milk and vertical transmission of HIV to the breastfeeding infant [6, 7] . The disease causes localized pain and is frequently accompanied by the rapid onset of systemic symptoms, including fever, muscle aches, chills, and fatigue [8] . In 3%-11% of cases, mastitis leads to a breast abscess [9] , which must be surgically drained, and in severe disease, there can be permanent disfiguration of the breast. Low milk supply frequently accompanies these symptoms, and combined, the challenges posed by this disease lead many women to cease breastfeeding [10] [11] [12] .
The relationship between mastitis in women and bacterial infection has been largely inferred through studies in bovine species [13] and the identification of pathogenic bacteria including Staphylococcus aureus, Escherichia coli, and Group B streptococci in mastitis-affected human breast milk [14, 15] . However, there remains speculation as to how significant bacterial load is in the disease etiology. Nearly a third of healthy breastfeeding women harbor high bacterial counts of S. aureus in breast milk without clinical signs of mastitis, and 10% harbor Group B streptococci [15, 16] . These bacterial species are also commonly found in nasal passages and skin flora [17] [18] [19] . Emphasizing this dichotomy in our mechanistic understanding of mastitis, recent Cochrane systematic reviews have highlighted the uncertainty around the management of mastitis with antimicrobial agents because prophylactic antibiotic use does not appear to be effective in preventing mastitis [20] , and there is insufficient evidence to support the use of antibiotics in treating the disease [21] .
On the other hand, severity of mastitis is closely correlated with markers of inflammation, including C-reactive protein (CRP) and sodium [22, 23] . Women with mastitis frequently exhibit breast inflammation in the absence of abundant pathogenic bacteria, leading some researchers to delineate infectious and noninfectious forms of mastitis disease [24, 25] . Combined, these findings suggest that in some cases the presence of abundant bacterial pathogens is not sufficient to trigger the disease, and in other cases, bacteria are not the principle drivers of inflammation. As disease severity bares a closer relationship with markers of inflammation as opposed to bacterial load, immune-signaling pathways activated in the host may be highly significant in disease pathology.
Women with mastitis exhibit a systemic inflammatory response characterized by increased serum cytokines, including tumor necrosis factor alpha (TNFA) and interleukins (IL) 1, 6, and 8 [26, 27] . This is indicative of activation of the transcription factor nuclear factor kappa B (NFjB). Candidates responsible for activating NFjB include the toll-like receptors (TLRs). TLRs are pattern-recognition receptors expressed by many cell types, including epithelial and immune cells. TLRs recognize microbe-associated molecular patterns (MAMPs) on bacteria such as lipopolysaccharide (LPS), lipoteichoic acid, flagellin, peptidoglycan, and lipoprotein [28, 29] . TLRs expressed on the surface of macrophages, dendritic cells, and epithelial cells mediate secretion of a cascade of inflammatory cytokines, chemokines, and adhesion molecules and recruit other components of the innate immune system such as neutrophils to the infected site [30] .
Little is known of the significance of the host innate inflammatory response in the pathology of mastitis. In this study, we demonstrate that the loss of TLR4 in the host alters the immune-signaling fingerprint, with the response to mastitislike disease shifted toward greater local inflammation and a reduced systemic response. Mastitis induction did not compromise lactation capacity in Tlr4 null mutant mice, as was observed in wild-type mice, suggesting that perturbed milk supply during mastitis is a consequence of TLR4-mediated inflammation, rather than due to the bacterial infection itself. These results demonstrate that the host innate immune response activated in the mammary gland is a critical feature of mastitis disease and raises the possibility that mastitis may in some cases be the result of a heightened TLR4-mediated inflammatory response to an otherwise innocuous bacterium.
MATERIALS AND METHODS

Mice
All the animal experiments were approved by the University of Adelaide Animal Ethics Committee and conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (seventh edition, 2004). Mice were maintained in specific pathogen-free conditions with controlled light (12L:12D) and temperature at the University of Adelaide, Medical School Animal House. Female 8-wk old Tlr4 null mutant mice (Tlr4 À/À ) [31] on an inbred Balb/c background (provided by Prof Paul Foster, University of Newcastle, Australia) and wild-type (Tlr4 þ/þ ) Balb/c mice (Laboratory Animal Services, University of Adelaide, Australia) were impregnated by wild-type stud males, and pregnant female mice were housed individually.
Induction of Mastitis
The day of parturition was designated Lactation Day 1 (LD), at which time litter numbers were normalized to six to eight pups per litter to ensure sufficient and similar lactation between dams. On LD8-LD10, dams were anesthetized with 1% isoflurane. Because prolonged milk stasis leads to involution, which is characterized by infiltration of inflammatory cells into the mammary gland [32, 33] , the third right mammary teat was sealed as an involution control. The third left mammary teat was left intact as a lactation control. Ten microliters of Matrigel (BD Bioscience) containing 10 lg LPS as a model inflammatory stimulus (Sigma-Aldrich) was administered to the fourth right mammary gland via a 34 gauge needle attached to a 100 ll glass syringe, inserted into the mammary gland teat. PBS control in Matrigel was administered to the fourth left mammary gland. Dams recovered from anesthetic for 30 min then were returned to their litter.
Blood Collection
Blood was collected for assessment of serum cytokine levels by retro orbital bleeding during the experiment or by cardiac puncture at termination. Each mouse was bled immediately prior to mastitis induction, at termination, and at an intermediate time point (Table 1 ). Blood was clotted at room temperature for 30 min and then centrifuged at 2000 rpm for 10 min. Serum was carefully removed and stored at À808C until analysis.
Cytokine Assays
Serum concentration of CXCL1 was measured using the ELISA Duo-Set kit according to the manufacturer's instructions (R&D Systems). Serum interleukin 10 (IL10) concentration was measured in the ELISA Ready-SETGo kit according to the manufacturer's instructions (eBioscience). Serum concentrations of interleukins (IL) 1B, 2, 4, and 12, tumor necrosis factor alpha (TNFA), interferon gamma (IFNG), CCL2, and IP10 were measured by Luminex assay following the manufacturer's instructions (MILIPLEX MAP kit; Millipore).
Litter Weights
Litters were weighed immediately after mastitis induction and at the same time daily until termination.
Tissue Collection and Processing
Mice were terminated and tissue collected at one of four time points after mastitis induction: 8 h, 1 day, 3 days, or 7 days, with n ¼ 10-11 mice per time point per genotype. At euthanasia, the third and fourth pair mammary glands were dissected and fixed in 4% paraformaldehyde overnight and then processed and embedded in paraffin. Five micron sections were mounted on glass slides (Colour Frost; HD Scientific Supplies) for hematoxylin and eosin (H&E) staining to examine histological changes and for immunohistochemical analysis.
Immunohistochemistry
Mammary gland sections were dewaxed in Safsolvent, rehydrated in decreasing concentrations of ethanol, and rinsed in MQ-filtered water. Antigen retrieval was carried out on sections to be stained with antibodies against phosphorylated signal transducer and activator of transcription 5 (p-STAT5) and whey acidic protein (WAP) by microwaving sections for 20 min in 10 mM sodium citrate, pH 6.0 (WAP), or ethylenediaminetetraacetic acid, pH 8.0 (p-STAT5). Endogenous peroxidase activity was blocked with 1.5% hydrogen peroxide, and then nonspecific binding was blocked with 15% normal rabbit serum (Sigma-Aldrich) (F4/80 and RB6) or 10% normal goat serum (SigmaAldrich) (WAP and p-STAT5). Primary antibodies were then applied-F4/80 [BM8] (1:100; eBioscience), RB6-Ly-6G (1:500 rat hybridoma supernatant provided by Professor Sarah Robertson, University of Adelaide, Australia), p-STAT5 [C71E5] (1:400; Cell Signaling Technology), and WAP [R-131] (1:300; Santa Cruz)-at 48C overnight. Sections were washed and incubated with a biotinylated rabbit anti-rat immunoglobulin G (Vector Laboratories) for 40 min at room temperature followed by washing and incubation with Vectastain ABC kit (Vector Laboratories). Positive staining was developed using 3,3 0 -diaminobenzidine (DAKO Liquid DABþSubstrate Chromogen System; DAKO) and counterstained with hematoxylin. Tissue sections were then dehydrated in ethanol, cleared in Safsolvent, and mounted in Entellanmounting media (Merck). Each stained section had a matched negative control, having the primary antibody incubation step with diluent alone. Antibody specificity was also confirmed using an isotype-matched negative control antibody.
Quantification of Mammary Gland Histology
Images of H&E-and antibody-stained mammary gland sections were obtained by scanning the slides with a NanoZoomer (Hamamatsu). All the quantification was done by an assessor blinded to genotype, using NanoZoomer Digital Pathology Virtual Slide Viewer software (Hamamatsu). The affected area within H&E-stained glands was defined as an area where there was a dramatic influx of leukocytes or where there was apparent alveolar collapse. The area was calculated at 1.253 magnification as a percent of total mammary gland area. F4/80 and RB6 antibody-stained cells were counted in six and four randomly selected 403 magnification images, respectively, within the affected area and expressed as cells per mm 2 . In control tissue where there was no affected area, a similar region proximal to the teat was quantified. Percent GLYNN ET AL.
glandular area was assessed in mammary gland sections in an area adjacent to the lymph node distal to the teat on Days 1, 3, and 7 after mastitis induction by manually highlighting areas of epithelium, including luminal spaces, using ImageJ software at 53 magnification. Phosphorylated-STAT5 antibody stained sections were examined at 103 magnification across the entirety of the gland to assess the location of the staining within epithelial cells. Nuclear staining was recorded as a semiquantitative score of 0%-20%, 20%-40%, 40%-60%, 60%-80%, or 80%-100% for each mouse. To further quantify nuclear staining, every second sequential field of view was assessed semiquantitatively as before (approximately 30 fields per mouse), and the average score for each mouse was calculated.
Statistical Analysis
Data were analyzed by Univariate General Linear Model with Tukey post hoc to assess the time series, The Student t-test was used to compare cytokine production between wild type and control, and the chi-square test was used to assess distribution of nuclear p-STAT5 using IBM SPSS Statistics (IBM Corp.). Data are presented as the mean 6 SEM. P values , 0.05 were considered statistically significant.
RESULTS
The Effect of Administration of LPS in Matrigel to the Lactating Mammary Gland
Previous studies employing mouse models of lactation mastitis have not investigated the full course of the disease through to resolution and the consequences of inflammation on lactation [34] [35] [36] [37] . It was essential in this study to delineate mastitis-induced inflammation from mammary gland involution, which is caused by prolonged milk stasis and characterized by infiltration of inflammatory cells, including macrophages [32, 33] . Lactating Balb/c mice were injected via the teat canal with LPS (10 lg/10 ll) diluted in Matrigel, resulting in a small ductal blockage containing an inflammatory stimulus. LPS was used as a model inflammatory stimulus because we aimed to investigate host inflammation in mastitis rather than clearance of a bacterial pathogen. Over the following week, there were no overt signs of poor health. Pup weight was measured daily as a proxy for maternal wellness, which demonstrated continuous weight gain by pups over the period of the study (Fig. 1A) .
Histological analysis of the LPS-treated glands showed a marked influx of inflammatory cells into the alveoli and milk ducts with the affected area increasing in size at 3 days after mastitis induction (Fig. 1, B-D and F) . By 7 days postinduction, the inflammation had resolved and appeared histologically normal; however, in some mice, the LPS-treated gland appeared dysfunctional (Fig. 1E , left and right, respectively). This characteristic localized inflammation was not observed in untreated, teat-sealed, or Matrigel-only vehicle mammary glands (Fig. 1G-I, respectively) ; therefore, localized inflammation observed in LPS-treated glands was caused by LPS and was not the consequence of involution or Matrigel administration.
Immunohistochemistry was utilized to examine the influx of neutrophils and macrophages into the gland following mastitis 
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induction. RB6-positive neutrophils are rapidly recruited into the LPS-treated gland forming a dense region of staining ( Fig.  2A-D) . Neutrophil staining was predominantly observed in the alveoli and in the milk ducts. Neutrophils were quantified within the localized area of inflammation, demonstrating that this infiltration increases 8 h after mastitis induction, remains elevated at 1 day, and has subsided at Days 3 and 7 after induction (Fig. 2F ). There were very few neutrophils identified in untreated, teat-sealed, or Matrigel-only vehicle control mammary glands (Fig. 2G-I) . The spatial and temporal pattern of macrophage abundance differed from that of neutrophils (Fig. 3A-D) , with macrophage numbers within the localized area of inflammation significantly increasing 3 days after mastitis induction and remaining elevated at 7 days (Fig. 3F) . The macrophages were primarily located within the interstitial spaces between alveoli and in close association with the basal laminar of the alveoli. Macrophage abundance did not increase in Matrigel-only vehicle control glands at 1 or 3 days after induction compared to 8 h (Fig. 3, F and I) ; however, a significant increase was observed 7 days postinduction. This increased macrophage abundance was not observed in untreated control glands (Fig. 3G ). Macrophages were observed throughout the teat-sealed gland consistent with the process of involution (Fig. 3H) .
The Effect of Tlr4 Null Mutation on Mastitis Disease Progression
To investigate the contribution of TLR4 to mastitis disease progression and resolution, we utilized this mastitis model in Tlr4 null mutant (Tlr4 À/À ) mice compared to wild-type TLR4 replete (Tlr4 þ/þ ) mice. Pups born to Tlr4 À/À dams increased in weight over the 7 days following mastitis induction, and pup weight did not differ significantly compared to weight of pups born to Tlr4 þ/þ dams (data not shown). Staining by H&E of mammary glands permitted evaluation of the relative area in the gland that had undergone localized alveolar breakdown or damage. There were obvious areas of destruction in the glands of Tlr4 þ/þ and Tlr4 À/À mice; however, the percent of affected area did not differ between the strains (data not shown).
A marked influx of RB6-positive neutrophils into the LPSadministered gland was observed in both genotypes of mice at 8 h after mastitis induction and was sustained at Day 1 ( Fig.  4A-F) . Tlr4 À/À mice exhibited a significant 2-fold higher abundance of neutrophils compared to Tlr4 þ/þ at 8 h (Fig. 4M ). Neutrophilic inflammation was significantly reduced by 7 days postinduction compared to 8 h and 1 day postinduction. Low abundance of neutrophils was observed in untreated and teatsealed mammary glands from this same cohort of Tlr4 À/À mice on Day 1 after mastitis induction (Fig. 4, N and O,  respectively) .
The abundance of F4/80-positive macrophages also varied in mastitic mammary glands from Tlr4 À/À compared to Tlr4 þ/þ mice (Fig. 5) . There was an 80% higher abundance of GLYNN ET AL.
FIG. 2. LPS in Matrigel (10 lg/10 ll) induces localized neutrophil recruitment into the lactating mammary gland. Representative photomicrographs of anti-RB6 antibody-stained mammary glands collected 8 h (A), 1 day (B), 3 days (C), 7 days (D) after mastitis induction, and no primary antibody control (E). Normal uninterrupted lactation (G), involution induction via teat sealing (H), and
macrophages in Tlr4 À/À glands at Day 1, similar abundance at 3 days, and significantly reduced abundance at 7 days after mastitis induction compared to Tlr4 þ/þ glands.
The Effect of Tlr4 Null Mutation on Serum Cytokines
Our data suggests that TLR4 deficiency altered the kinetics of local inflammation in the mammary gland, and we sought to further investigate the systemic response to mastitislike disease. To examine the systemic effects of the locally applied LPS stimulus, blood was collected and serum analyzed for cytokine abundance. CXCL1 is the mouse homologue of IL8, which is elevated in women during mastitis [26, 27] . Serum CXCL1 concentrations in Tlr4 þ/þ mice following mastitis induction increased 240-fold from pretreatment concentration 4 h postinduction and declined rapidly (Fig. 6A) . The acute increase in CXCL1 serum levels in Tlr4 À/À mice exhibited a similar pattern. However, the magnitude of the response was attenuated at 4 h following mastitis induction compared to Tlr4 þ/þ mice. Acute serum IL1B, IL6, IL10, TNFA, CCL2, and IP10 concentrations in Tlr4 À/À mice were also significantly attenuated compared to Tlr4 þ/þ mice at 4 h after mastitis induction (Fig. 6B) . However, other cytokines, including IL2, IL4, and IL12, were not significantly attenuated.
The Effect of Tlr4 Null Mutation on Lactation Following Mastitis
Because inflammation has the potential to be deleterious to the functional capacity of the lactating gland, we investigated the consequence of induction of mastitislike disease on lactation in Tlr4 þ/þ and Tlr4 À/À mice. One week following induction of mastitislike disease, areas of the gland populated by adipose tissue were observed in wild-type mice, suggesting that some areas of the gland had undergone involution; these were not observed in Tlr4 À/À mice (Fig. 7, A and B, respectively). The percent area of the gland populated by glandular epithelium was quantified to assess the capacity for milk protein synthesis; this analysis was conducted in an area of the gland distal to the localized area where inflammation had been induced. On Days 1 and 3 following mastitis induction, the LPS-treated mammary gland from both genotypes was densely populated with glandular epithelium consistent with a high capacity for milk production. On Day 7, the glandular area was reduced in Tlr4 þ/þ mice; however, it remained high in Tlr4 À/À mice (Fig. 7C ). In the alveolar epithelial structures observed on Day 7, the milk protein WAP was detected in both genotypes (Fig. 7, D and E) and was not observed in negative controls (Fig. 7F) . Phosphorylated-STAT5 (p-STAT5) antibody was used to investigate activation of the alveolar epithelial cells to produce milk proteins. Mammary alveolar epithelium from both genotypes of mice stained positive for p-STAT5 at 7 days after mastitis induction (Fig. 7G-I ) and was not observed in negative controls (Fig. 7J) . The positive 
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þ/þ and Tlr4 À/À mice was clearly observed in distinct locations within the epithelial cells: within the cytoplasm of the cell (Fig. 7G) , within the nucleus (Fig. 7I), or both (Fig. 7H) . The distribution of p-STAT5 staining within epithelial cells was altered by genotype. More Tlr4 À/À mice exhibited p-STAT5 staining, predominantly in the nucleus ( Fig. 7K; P , 0.05 ), compared to Tlr4 þ/þ mice where less staining was observed in the nucleus and the predominance of staining was observed in the cytoplasm. When the percent of nuclear staining was quantified for each mouse, more nuclear staining was observed in Tlr4 À/À mice compared to Tlr4 þ/þ mice (Fig. 7L) . 
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DISCUSSION
Lactation mastitis is a poorly understood disease with scarce scientific literature to support the use of currently employed pharmacological treatment strategies [21] . Although bacterial infection is clearly associated with the disease, severity of mastitis is correlated with markers of inflammation [22, 23] rather than bacterial load [15] . Therefore, the specific immunesignaling pathways activated in the host tissue are likely to be key determinants of disease severity and the impact of mastitis on lactation. We have sought to understand the disease from the perspective of the host inflammatory response and have demonstrated that TLR4 signaling affects local and systemic inflammatory responses and lactation. Quantification of histological analysis (M). Data are mean 6 SEM of n ¼ 10-11 mice per time point. Asterisk denotes significant difference between genotypes at specific time points (*P , 0.05).
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Previous studies that employed mouse models of lactation mastitis did not investigate the full course of the disease through to resolution and continued capacity for milk production [34] [35] [36] [37] . Reduced milk production is caused by a process known as involution, which is characterized by infiltration of inflammatory cells, including macrophages [32, 33] , which may appear similar to inflammation associated with mastitis. We have modified the existing disease model and extended previous studies to investigate this. In our mouse model, a localized area of inflammation in the mammary gland is induced, accompanied by a systemic immune response. Involution in the LPS-treated mammary gland is not induced initially, as demonstrated by altered kinetics of macrophage and neutrophil infiltration in this gland compared to the teatsealed mammary gland control. However, many of the LPStreated glands appeared to have reduced lactation on Day 7 postinduction, and it is likely that involution occurred in some mice as a consequence of LPS-induced inflammation. Interestingly, macrophage abundance in LPS-treated glands remains high in wild-type mice and increases over 7 days in Matrigelonly-treated glands, suggesting that macrophages are necessary to assist in clearance of the Matrigel. Importantly, there is no early indication of inflammation in the Matrigel-only-treated gland or of involution because the gland appeared fully functional for the entirety of the study.
Utilizing this mouse model, we investigated the contribution of TLR4 in lactation mastitis. Our data show amplified neutrophil and macrophage infiltration in the absence of TLR4 in the early stages of the disease, accompanied by dampened systemic cytokine responses. TLRs act in a cooperative, complementary, and compensatory fashion with a number of other innate immune sensors, including nucleotide oligomerization domain proteins, C-type lectin receptors, and RIG-I-like receptors [38] and LPS-induced immune responses in the genetic absence of TLR4 are previously reported [39, 40] . Therefore, the loss of TLR4 signaling alters the signaling fingerprint to LPS rather than simply suppressing the innate immune response.
Our results suggest that TLR4 deficiency shifts the immune response to mastitislike disease toward greater local inflammation and a reduced systemic response. It was surprising that an amplified neutrophil response was observed in the context of dampened serum CXCL1, which is a significant chemoattractant for neutrophils. However, the temporal and spatial abundance of CXCL1 is critical to the establishment of the chemoattractant gradient, with elevated endothelial cell CXCL1 leading to inhibition of neutrophil transendothelial migration into tissues [41] . Therefore, dampened systemic CXCL1 may cause an increase in the chemoattractant gradient. Intramammary cytokine and chemokine abundance was not assessed in this study; however, it is possible that chemoattractant factors such as CXCL1 were elevated locally, leading to greater influx of neutrophils to the mammary gland. Other cytokines, including IL2, 4, and 12, were not significantly attenuated in Tlr4 null mice, and their elevation may also have contributed to the influx of inflammatory cells to the mammary glands of these mice. In addition, serum IL10, which inhibits neutrophil priming and autocrine activation [42] , was also significantly dampened, suggesting that increased immune cell infiltration in TLR4-deficient mice could be a consequence of reduced inhibitory signaling.
We did not assess the effect of the shift toward a greater local response in Tlr4 null mice on resolution of an active bacterial infection. However, a more vigorous immune response appears to be beneficial in resistance to mastitis [43] , and the altered immune-signaling fingerprint in the absence of TLR4 may mediate this. In bovine species, polymorphisms in the Tlr4 gene affect mastitis disease susceptibility [44, 45] , and a high proliferative response of peripheral blood mononuclear cells exposed to LPS in vitro may be associated with increased resistance to mastitis [46] .
The results from the current study clearly implicate the host innate inflammatory response as an integral component of the disease that may affect susceptibility, severity, and resolution of mastitis. Blocked milk ducts or maternal stress, which are significant risk factors for mastitis [1, 3, 47] , may affect the expression of mRNA encoding TLR4, the abundance of costimulatory factors such as danger-associated molecular patterns (DAMPs), or downstream immune-signaling pathways. DAMPs are endogenous factors that stimulate TLRs in addition to MAMPs such that inflammation can be induced under sterile conditions. In a blocked milk duct, under mechanical stress from the increased abundance of milk, a number of DAMPs, including HMGB1 and HSP70, may accumulate and augment inflammatory responses to MAMPs [48] . The abundance of lactate, a potent activator of the TLR4-signaling pathway and NFjB [49] , increases in bovine milk during mastitis [50] and may also act as a costimulatory inflammatory factor. The sensitivity of the mammary gland to both DAMPs and MAMPs may be increased due to maternal stress, which potentially alters expression of mRNA encoding TLR4 or downstream signaling pathways [51, 52] . Therefore, GLYNN ET AL. mastitis disease may in some cases be the result of a heightened TLR4-mediated inflammatory response to an otherwise innocuous bacterium.
One week following induction of mastitislike disease, wildtype mice had reduced capacity for lactation. Milk-secreting glandular area was reduced, and much of the gland was repopulated with adipose tissue, suggesting that partial mammary gland involution had occurred. Although the epithelial ducts that remained exhibited evidence of continued milk protein production, p-STAT5 was predominantly cytoplasmic in location. Phosphorylation of STAT5 and subsequent translocation to the nucleus is necessary for activation of milk protein synthesis [53] , and the predominantly cytoplasmic location of p-STAT5 in wild-type mice suggests a compromised capacity to produce milk in the remaining glandular epithelium. Lactation insufficiency in mice has also been observed as a consequence of inappropriate adaptive immune responses [54] , suggesting lactation capacity can become compromised as a result of an immune response in the absence of active infection or milk stasis. Reduced milk supply observed in women with mastitis could therefore be a consequence of a TLR4-mediated immune response leading to partial involution. Similarly, subclinical mastitis in women, characterized by increased IL8 and sodium in breast milk in the absence of clinical disease symptoms [55] , is associated with poor weight gain in infants [55, 56] and might be the result of a TLR4-mediated inflammatory response causing prolonged reduction in milk synthesis in the mother. Although we did not observe reduced weight gain in pups born to wild-type dams compared to Tlr4 null dams, our data suggest that this would occur if mastitislike disease was induced in all 10 mammary glands.
Lactation mastitis has been linked to an increased risk of breast cancer [57] . A population-based study of over 2 million women identified a 23% increased risk of breast cancer in women with a history of mastitis requiring hospitalization FIG. 7 . Tlr4 null mutation may protect the mastitic lactating mammary gland from a loss of function. Representative photomicrographs of glands collected 7 days after mastitis induction from Tlr4 þ/þ (A, D, G) and Tlr4 À/À (B, E, I) mice. Glands were stained with H&E (A and B) 203 magnification (bars ¼ 100 mm) and assessed for percent glandular area (C). Anti-WAP antibody (D and E) and anti-p-STAT5A antibody (G, H, and I) are shown here at 403 magnification (bars ¼ 50 mm). Negative controls for WAP (F) and p-STAT5 (J) showed no staining. Graphical representation of p-STAT5 staining locality (K and L). Data are mean 6 SEM of n ¼ 10-11 mice per time point (C and L) and number of mice in each category at the 7 day time point (K). Asterisk denotes significant difference between genotypes (*P , 0.05).
compared to women with no history of mastitis when adjusted for age, parity, and age at first birth [57] . The link is unlikely to be causal because there was no correlation between laterality of the mastitis-and cancer-affected breast. However, there are possible associations between breast cancer risk and polymorphisms in genes encoding TLRs and downstream NFjBsignaling mediators [58] , suggesting that inflammatory pathways may affect the development of breast cancer. Furthermore, prophylactic use of nonsteroidal anti-inflammatory drugs may protect against breast cancer [59, 60] and may be particularly significant in reducing postpartum breast cancer risk [61] . Therefore, women who are predisposed to TLR4-mediated inflammation during lactation may also be at an increased risk of breast cancer.
Mastitis is a common inflammatory disease that can cause severe local and systemic symptoms in breastfeeding women. We have demonstrated that the progression of mastitislike disease in mice is affected by the engagement of TLR4. In the absence of TLR4, there is increased local inflammation and decreased systemic response early in the disease, and lactation capacity is less compromised at resolution. We propose that heightened TLR4 signaling in the host due to milk stasis, maternal stress, or genetic predisposition may in some cases cause mastitis in response to an otherwise innocuous bacterium. These findings may provide opportunities to develop novel treatment strategies for lactation mastitis.
ACKNOWLEDGMENT
Thank you to Professor Paul Foster, University of Newcastle, for provision of Tlr4 null mice and Professor Sarah Robertson for provision of the RB6 antibody.
